Genmab — Juni 2023

[E_L]

longer term results of patients with DLBCL treated with epcoritamab+R-CHOP. The latest results support the preliminary data and this treatment induces high CMR rates with a manageable safety profile https://twitter.com/lymphomahub/status/1666142892270682128

[Bulder]

Dansk begejstring over FDA-godkendelse af epcoritamab: Det er et stort fremskridt

[Bulder]

Dansk begejstring over FDA-godkendelse af epcoritamab: Det er et stort fremskridt

De amerikanske lægemiddelmyndigheder FDA har godkendt det bispecifikke antistof epcoritamab til behandling af patienter med relaps eller refraktært (r/r) storce

(haematologisktidsskrift.dk)

[Bulder]

God og grundig artikel, der belyser “styrkeforholdet” epco/glofi/car-t.

[Pensionisten]

Tak for den gode artikel, @Bulder. Den var til at forstå - selv for mig! Og det siger ikke så lidt

[E_L]

Epcoritamab Plus Rituximab/Lenalidomide Produces Responses in High-risk R/R Follicular Lymphoma https://www.onclive.com/view/epcoritamab-plus-rituximab-lenalidomide-produces-responses-in-high-risk-r-r-follicular-lymphoma (this was the oral presentation)

[E_L]

Epcoritamab + R2 regimen and responses in high-risk follicular lymphoma, regardless of POD24 status. https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.7506?af=R

[E_L]

so the first article is the new/later cutoff date of January 31, 2023; results very similar

[E_L]

104 efficacy evaluable patients treated with epcoritamab at 48 mg plus R2, the overall response rate (ORR) was 98% (median follow-up, 11.4 months). The complete metabolic response (CMR) was
87%

[E_L]

(versus the the immediate prior therapy they progressed on,
85% and 58% respectively)

[E_L]

easier article maybe - Positive Responses Seen in Follicular Lymphoma When Epcoritamab Is Added to Rituximab and Lenalidomide https://dailynews.ascopubs.org/do/positive-responses-seen-follicular-lymphoma-epcoritamab-added-rituximab-and

[Bulder]

As far as I remember Genmab was planning to file epco for approval in FL this year. But I don’t remember if it was RR or 1L. Do you?

[E_L]

oh good question, i had assumed RR as that is usually the case for a first approval
...

[Helge_LarsenPI-redaktør]

Godmorgen

[Stroka]

God morgen

[ProinvestorNEWS]

Shortpositioner på danske aktier https://www.proinvestor.com/boards/113022

[Klarussen]

Short Genmab stabil 0,43%, fint, fint. Og det gode ved shorts er jo at de skal købes tilbage på et tidspunkt som Buffet siger

[AaBforever]

Ja spændende hvornår turen op til 3500 starter...;-)

[Riis7]

Buffet køber ikke aktier unden udbytte og aktietilbagekøbs program:-) Genmabs aktietilbagekøbs program er kun til deres medarbejder:-)

[StockBull]

Den startede i 2010 men som med kurs 2000 tager det også lidt tid at bryde 3000 niveau. Den gode nyhed er 4000 og 5000 kommer til at gå hurtigere så længe de fortsætter med +35% årlig vækst